merger

Eli Lilly announces $7-billion merger, with eye on wakefulness drugs. The deal with London and Boston-based biotech company Centessa could have implications for treating Alzheimer’s.

House lawmakers passed a bill Tuesday that requires hospitals and other health care entities to notify the attorney general if they have a merger or acquisition that crosses a $10 million threshold.